Federal authorities are investigating after some COVID-19 vaccine recipients have developed the rare blood disorder thrombocytopenia.

Two officials from the U.S. Food and Drug Administration (FDA) don’t recommend doses for the CCP virus vaccine to be cut in half in order to ...

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges ...

A vaccine candidate jointly developed by Moderna and the National Institutes of Health (NIH) has been shown to be 94.5 percent effective.

The Trump administration has struck a deal with Massachusetts-based drugmaker Moderna to secure 100 million doses of its potential CCP virus vaccine. “This evening I’m pleased ...

Monkeys deliberately infected with the CCP virus and given Moderna’s experimental COVID-19 vaccine were able to quickly clear the virus from their lungs.

Drugmaker Moderna has obtained clearance from the Food and Drug Administration to run a larger trial of its CCP virus vaccine candidate.

Moderna, a U.S.-based drugmaker, has sent the first batch of an experimental vaccine against the new coronavirus to federal researchers to use with humans.